
|Articles|July 1, 2001
The American Journal of Managed Care
- July 2001
- Volume 7
- Issue 7
Economic Evaluation of Lamivudine Compared with Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
How Medicaid Reforms Could Deepen State Coverage Gaps
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5